Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Gastric Volvulus Treatment Market Grown from 2024 to 2025?

In recent times, the market size for gastric volvulus treatment has seen robust growth. The market is anticipated to surge from $27.36 billion in 2024 to an increased value of $28.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The substantial growth noted in the historic period is due to factors such as developments in surgical procedures, enhancements in diagnostic technologies, heightened awareness and education, growth in minimally invasive procedures, and ongoing research and clinical studies.

What Growth Rate Is Anticipated for the Gastric Volvulus Treatment Market in the Coming Years?

In the coming years, the market for gastric volvulus treatment is expected to experience significant growth, reaching a value of $37.48 billion in 2029, with an annual compound growth rate of 6.7%. Factors contributing to this growth during the forecast period include regulatory shifts and approvals, advancements in surgery methods, increase in the elderly population, personalized treatment programs, and the usage of high-tech imaging techniques. The major trends projected for this period include a shift towards less invasive surgical techniques, a rise in early intervention and awareness, advances in treatment approaches, increased collaboration in medical practices, and tailored treatment options.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Who Are the Leading Companies in the Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

What Are the Key Drivers of the Gastric Volvulus Treatment Market?

The upsurge in the elderly population is projected to drive the growth of the gastric volvulus treatment market. Often called the geriatric population, this group includes adults aged 65 and above who are prone to multiple infections due to decreased immunity and elderly age. Gastric volvulus is specifically found in individuals above fifty years old, implying that an increase in the aging population would expedite the market growth. As an illustration, the Population Reference Bureau (PRB), a nonprofit organization based in the US, predicts in January 2024 that the number of Americans aged 65 and above will skyrocket from 58 million in 2022 to 82 million in 2050, envisioning a 47% upsurge. Furthermore, the percentage of this group in the overall population is forecasted to rise from 17% to 23%. Consequently, with the upswing in older populations, the gastric volvulus treatment market is being given a significant boost.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

What Are the Key Market Segments in the Gastric Volvulus Treatment Industry?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

What Are the Latest Trends in the Gastric Volvulus Treatment Market?

Innovations in product development are an emerging trend within the gastric volvulus treatment sector, with leading companies launching unique products to maintain market stronghold. For example, Pfizer Inc., an American pharmaceutical titan, revealed in October 2023 that the U.S. Food and Drug Administration (FDA) had sanctioned VELSIPITY (etrasimod), a once-daily oral pill for individuals dealing with moderate to severe active ulcerative colitis (UC). Officially, the recommended dosage for VELSIPITY is 2 mg. It enables adult patients with moderate to severe active UC to achieve a steroid-free resolution courtesy of a single daily pill with a favourable benefit-risk ratio. With the FDA’s endorsement, VELSIPITY stands as a critical game-changer for UC patients seeking new treatments for their chronic condition and are prepared for advanced treatment.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

What Are the Key Regional Markets in the Gastric Volvulus Treatment Industry?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

This Report Delivers Insight On:

1. How big is the gastric volvulus treatment market, and how is it changing globally?

2. Who are the major companies in the gastric volvulus treatment market, and how are they performing?

3. What are the key opportunities and risks in the gastric volvulus treatment market right now?

4. Which products or customer segments are growing the most in the gastric volvulus treatment market?

5. What factors are helping or slowing down the growth of the gastric volvulus treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model